Adjuvance Technologies is a privately held biopharmaceutical company dedicated to empowering health through fundamental breakthroughs in vaccine adjuvant design and manufacturing. Adjuvants are critical components that are added to many vaccines to improve the immune response.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Nebraska
Company HQ Country:
United States
Year Founded:
2009
Main Therapeutic Focus:
Infectious Diseases
Lead Product in Development:
TQL1055
Development Phase of Primary Product:
Pre-Clinical
Number Of Unlicensed Products (For Which You Are Seeking Partners):
1
Speaker
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
